Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders

BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders

US Patent 9545086 · Granted Jan 17, 2017

Estimated economic value: $450,849,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating complement mediated diseases with fusion protein constructs 2024
Anti-BCMA antibodies2021
Fusion protein constructs comprising anti-C3d antibody and CR1 polypeptide2021
Fusion protein constructs comprising anti-C3d antibody and factor H2021
Methods of modulating immune responses using BCMA polypeptide2019
Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA)2017
Methods of treating a patient having an autoimmune disorder by administering a s2016
Methods of evaluating BAFF2015
Anti-BCMA antibodies2015
Methods of screening for a compound that inhibits the interaction between BAFF a2014
Method of treating a patient having an autoimmune disorder by administering BAFF2014
Methods of evaluating BAFF2014